Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion

被引:1
|
作者
Barletta, Francesco [1 ,2 ,3 ]
Tappero, Stefano [1 ,3 ,4 ,5 ]
Morra, Simone [1 ,3 ,6 ]
Incesu, Reha-Baris [1 ,3 ,7 ]
Garcia, Cristina Cano [1 ,3 ,8 ]
Piccinelli, Mattia Luca [1 ,3 ,9 ]
Scheipner, Lukas [1 ,3 ,10 ]
Baudo, Andrea [1 ,3 ,11 ,12 ]
Tian, Zhe [1 ,3 ]
Gandaglia, Giorgio [2 ]
Stabile, Armando [2 ]
Mazzone, Elio [2 ]
Terrone, Carlo [4 ,5 ]
Longo, Nicola [6 ]
Tilki, Derya [2 ,7 ,13 ,14 ]
Chun, Felix K. H. [8 ]
de Cobelli, Ottavio [9 ]
Ahyai, Sascha [10 ]
Carmignani, Luca [11 ,12 ]
Saad, Fred [3 ]
Shariat, Shahrokh F. [15 ,16 ,17 ,18 ]
Montorsi, Francesco [2 ]
Briganti, Alberto [2 ]
Karakiewicz, Pierre I. [1 ,3 ]
机构
[1] Univ Montreal, Hlth Ctr, Div Urol, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
[2] IRCCS San Raffaele Sci Inst, Div Oncol, Gianfranco Soldera Prostate Canc Lab, Unit Urol, I-20132 Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] IRCCS Policlin San Martino, Dept Urol, Genoa, Italy
[5] Univ Genoa, Dept Surg & Diagnost Integrated Sci DISC, Genoa, Italy
[6] Univ Naples Federico II, Dept Neurosci Sci Reprod & Odontostomatol, Naples, Italy
[7] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[8] Goethe Univ Frankfurt Main, Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany
[9] IRCCS, IEO European Inst Oncol, Dept Urol, Milan, Italy
[10] Med Univ Graz, Dept Urol, Graz, Austria
[11] IRCCS Osped Galeazzi St Ambrogio, Dept Urol, Milan, Italy
[12] IRCCS Policlin San Donato, Dept Urol, Milan, Italy
[13] Univ Hosp Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[14] Koc Univ Hosp, Dept Urol, Istanbul, Turkiye
[15] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
[16] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[17] Univ Texas Southwestern, Dept Urol, Dallas, TX USA
[18] AL Ahliyya Amman Univ, Hourani Ctr Appl Sci Res, Amman, Jordan
关键词
SEER program; Prostate cancer; Organ confined; GALLIUM NITRIDE; EXTRAPROSTATIC EXTENSION; REMOVAL MECHANISM; SUBSURFACE DAMAGE; GAN; SURVIVAL; SIMULATION; PARAMETERS; GROWTH; RF;
D O I
10.1016/j.clgc.2023.05.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is not clear whether cancer specific mortality (CSM) differences exist in radical prostatectomy (RP) treated prostate cancer (PCa) patients with specimen-confined (pT2) stage according to presence of lymph node invasion (LNI). Overall, 32,258 patients with pT2 PCa at RP + LND were identified. Of these, 448 (1.4%) patients harbored LNI. In multivariable Cox-regression models pN1 independently predicted higher CSM (HR: 4.4, P < .001). In sensitivity analyses addressing pT2 pN1 patients, 5-year CSM-free estimates were 99.3, 100 and 84.4% for ISUP GG 1-3 vs. 4 vs. 5, respectively ( P < .001). These findings might be of value for clinical decision making, as well as for individual patient counseling.Purpose: To test cancer-specific mortality (CSM) differences in specimen-confined (pT2) prostate cancer (PCa) at radical prostatectomy (RP) with lymph node dissection (LND) according to lymph node invasion (LNI). Methods: RP + LND pT2 PCa patients were identified (surveillance, epidemiology, and end results 2010-2015). CSM-FS rates were tested in Kaplan-Meier plots and multivariable Cox-regression (MCR) models. Sensitivity analyses respectively addressing patients with 6 or more lymph nodes analyzed and pT2 pN1 patients were performed. Results: Overall, 32,258 patients with pT2 PCa at RP + LND were identified. Of these, 448 (1.4%) patients harbored LNI. Five-year CSM-free estimates were 99.6% for pN0 vs. 96.4% for pN1 (P < .001). In MCR models, pN1 (HR: 3.4, P < .001) independently predicted higher CSM. In sensitivity analyses addressing patients with 6 or more lymph nodes analyzed (n = 15,437), 328 (2.1%) pN1 patients were identified. In this subgroup, 5-year CSM-free estimates were 99.6% for pN0 vs. 96.3% for pN1 (P < .001) and, in MCR models, pN1 independently predicted higher CSM (HR: 4.4, P < .001). In sensitivity analyses addressing pT2 pN1 patients, 5-year CSM-free estimates were 99.3, 100 and 84.8% for ISUP GG 1-3 vs. 4 vs. 5, respectively (P < .001). Conclusions: In patients with pT2 PCa a small proportion harbor LNI (1.4%-2.1%). In such patients, CSM rate is higher (HR 3.4-4.4, P < .001). This higher CSM risk seems to virtually exclusively apply to ISUP GG5 patients (84.8% 5-year CSM-free rate).
引用
收藏
页码:E461 / +
页数:7
相关论文
共 50 条
  • [1] Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients
    Barletta, Francesco
    Tappero, Stefano
    Morra, Simone
    Incesu, Reha-Baris
    Garcia, Cristina Cano
    Piccinelli, Mattia L.
    Scheipner, Lukas
    Tian, Zhe
    Gandaglia, Giorgio
    Stabile, Armando
    Mazzone, Elio
    Terrone, Carlo
    Longo, Nicola
    Tilki, Derya
    Chun, Felix K. H.
    de Cobelli, Ottavio
    Ahyai, Sascha
    Saad, Fred
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Briganti, Alberto
    Karakiewicz, Pierre I.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (07) : 1305 - 1310
  • [2] The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients
    Wenzel, M.
    Wuernschimmel, C.
    Nocera, L.
    Colla, Ruvulo C.
    Shariat, S. F.
    Briganti, A.
    Graefen, M.
    Kluth, L. A.
    Mandel, P.
    Chun, F. H. K.
    Karakiewicz, P. I.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S1720 - S1720
  • [3] The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients
    Wenzel, Mike
    Wurnschimmel, Christoph
    Nocera, Luigi
    Colla Ruvolo, Claudia
    Tian, Zhe
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    Graefen, Markus
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre I.
    [J]. PROSTATE, 2021, 81 (06): : 339 - 346
  • [4] Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer
    Lughezzani, Giovanni
    Gallina, Andrea
    Larcher, Alessandro
    Briganti, Alberto
    Capitanio, Umberto
    Suardi, Nazareno
    Lista, Giuliana
    Abrate, Alberto
    Sangalli, Mattia Nicola
    Buffi, Nicolomaria
    Cestari, Andrea
    Guazzoni, Giorgio
    Rigatti, Patrizio
    Montorsi, Francesco
    [J]. BJU INTERNATIONAL, 2013, 111 (05) : 723 - 730
  • [5] Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection
    Preisser, Felix
    Nazzani, Sebastiano
    Bandini, Marco
    Marchioni, Michele
    Tian, Zhe
    Montorsi, Francesco
    Saad, Fred
    Briganti, Alberto
    Steuber, Thomas
    Budaeus, Lars
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    Karakiewicz, Pierre I.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 365.e1 - 365.e7
  • [6] PREDICTION MODEL FOR SIDE-SPECIFIC LYMPH NODE INVASION IN RADICAL PROSTATECTOMY AMONG PATIENTS WITH PROSTATE CANCER: FEASIBILITY OF SIDE-SPECIFIC LYMPH NODE DISSECTION
    Fukagawa, Eri
    Numao, Noboru
    Yamamoto, Shinya
    Yoshitomi, Kasumi
    Hamada, Kosuke
    Yoneoka, Yusuke
    Fujiwara, Motohiro
    Fujiwara, Ryo
    Komai, Yoshinobu
    Oguchi, Tomohiko
    Yuasa, Takeshi
    Fukui, Iwao
    Yonese, Junji
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E270 - E270
  • [7] Cancer-specific mortality is increased by erythrocyte transfusion in patients undergoing radical retropubic prostatectomy
    Routh, JC
    Slezak, JM
    Frank, I
    Blute, ML
    Kwon, ED
    Leibovich, BC
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 517 - 517
  • [8] Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer
    Nason, G. J.
    O'Connor, E. M.
    MacMahon, D.
    Moss, B.
    Considine, S. W.
    Cahill, A.
    O'Rourke, C.
    O'Brien, F. M.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (01) : 33 - 37
  • [9] Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer
    G. J. Nason
    E. M. O’Connor
    D. MacMahon
    B. Moss
    S. W. Considine
    A. Cahill
    C. O’Rourke
    F. M. O’Brien
    [J]. Irish Journal of Medical Science (1971 -), 2018, 187 : 33 - 37
  • [10] Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion
    Preisser, Felix
    Bandini, Marco
    Marchioni, Michele
    Nazzani, Sebastiano
    Tian, Zhe
    Pompe, Raisa S.
    Fossati, Nicola
    Briganti, Alberto
    Saad, Fred
    Shariat, Shahrokh F.
    Heinzer, Hans
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    Karakiewicz, Pierre I.
    [J]. PROSTATE, 2018, 78 (06): : 469 - 475